Gynesonics

Focus: Gynesonics is a women's health medical device company focused on uterine fibroids ablation, operating as a focused specialist in the gynecology space from Redwood City, CA.

Women's Health

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Gynesonics

AI assessmentNot Hiring

No open roles listed right now. Follow Gynesonics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

7 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Sonata System

Uterine Fibroid

N/A

Clinical Trials (1)

NCT03118037Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry

N/A

Help build intelligence for Gynesonics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused mission in underserved women's health market with clear unmet need in uterine fibroids treatment
Ground-floor opportunity at a device-stage company with active clinical development (7 active trials)
Small team environment (hiring 2 active roles) allows direct impact on product development and commercialization

Watch Out For

Pre-revenue biotech status creates financial uncertainty and longer path to stability than established peers
Minimal hiring activity (2 open roles total) suggests limited growth trajectory or capital constraints

Generated by Claude from Gynesonics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

VizAblate System

Menorrhagia

N/A

Clinical Trials (1)

NCT01998854Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation

N/A

VizAblate System

Leiomyoma

N/A

Clinical Trials (1)

NCT01226290Fibroid Ablation Study

N/A

Intrauterine Ultrasound-Guided Radiofreq. Ablation System

Menorrhagia

N/A

Clinical Trials (1)

NCT02228174Sonography Guided Transcervical Ablation of Uterine Fibroids